The Team





When not serving as the R&D strategist at Gadusol Labs, Dr. Mahmud is a Professor in the College of Pharmacy and Adjunct Professor in the Department of Chemistry at Oregon State University. Dr. Mahmud brings over 25 years experience working on natural products chemistry and biosynthesis, and has published 83 peer-reviewed articles, a book chapter, and filed 6 patent applications. Prior to working at OSU, he was a Research Assistant Professor and Postdoctoral Research Associate at the University of Washington. He received his Ph.D. and M.Sc. from Osaka University, and his Apothecary and B.S. from the University of North Sumatra. Dr. Mahmud’s research interests are broadly in bioorganic and natural products chemistry; biosynthesis of microbial secondary metabolites; and the interface of molecular genetics, enzymology, and chemistry to create and develop novel pharmaceutically active leads. His group discovered the genes responsible for the production of gadusol in fish and other vertebrates, and has been collaborating with Dr. Bakalinsky to produce the compound in yeast.

Alan Bakalinsky.JPG

Dr. Alan BAkalinskY



Dr. Bakalinsky serves as Director of Research at Gadusol Laboratories and Associate Professor at the Department of Food Science and Technology at Oregon State University. He is also Adjunct Associate Professor in the Departments of Microbiology and Biochemistry/Biophysics at OSU. Dr. Bakalinsky’s research focuses on the physiology of yeast fermentation. He has published 45 peer-reviewed articles, including a recent eLife paper that describes the discovery of the gadusol biosynthetic gene cluster and its heterologous expression in yeast. His early work focused on a widely-exploited but poorly understood trait of wine strains of Saccharomyces cerevisiae—resistance to sulfite. His genetic and molecular genetic analysis discovered a novel sulfite efflux pump and a control mechanism that accounted for the resistance. His more recent work has focused on cellulosic ethanol and the physiology of acid stress. His key contribution was documenting a general sensitivity towards acid stress shared by auxotrophs which explains why repeated screens of widely-used mutant libraries have not generated highly-resistant strains

Katie Pettinger.jpg



In her most recent position at Oregon BEST, Katie interfaced with researchers at Oregon research universities, identifying research projects with a high potential to lead to clean technology commercialization and providing funding recommendations for late stage R&D projects. She has several years of experience working in technology transfer and business development at the Department of Energy's National Energy Technology Laboratory (NETL), where she held leadership roles and worked to move inventions out of the lab and into the marketplace. Katie also served as VP of Operations for a entrepreneurship training nonprofit. She holds an MBA with a focus in technology commercialization from OSU.  



Commercialization analyst

Dr. Michael Berry is an engineer and an MBA who is an expert in evaluating technologies, performing market analyses, and developing business strategies. His experience with business model generation and lean methods are being used to help build company value and inform strategic operations at Gadusol Laboratories.